Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
RMC-6236
i
Other names:
RMC-6236, RMC6236, RMC 6236
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Revolution Medicines
Drug class:
RAS inhibitor
Related drugs:
‹
JZP815 (2)
RMC-7977 (2)
IODVA1 (1)
NEO100 (1)
DO-2 (0)
GI-4000 (0)
antroquinonol (0)
KY1022 (0)
PRLX 93936 (0)
JZP815 (2)
RMC-7977 (2)
IODVA1 (1)
NEO100 (1)
DO-2 (0)
GI-4000 (0)
antroquinonol (0)
KY1022 (0)
PRLX 93936 (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
KRAS G12
Non Small Cell Lung Cancer
KRAS G12
Non Small Cell Lung Cancer
RMC-6236
Sensitive: C2 – Inclusion Criteria
RMC-6236
Sensitive
:
C2
RMC-6236
Sensitive: C2 – Inclusion Criteria
RMC-6236
Sensitive
:
C2
KRAS G12
Pancreatic Ductal Adenocarcinoma
KRAS G12
Pancreatic Ductal Adenocarcinoma
RMC-6236
Sensitive: C3 – Early Trials
RMC-6236
Sensitive
:
C3
RMC-6236
Sensitive: C3 – Early Trials
RMC-6236
Sensitive
:
C3
KRAS mutation
Pancreatic Ductal Adenocarcinoma
KRAS mutation
Pancreatic Ductal Adenocarcinoma
RMC-6236
Sensitive: D – Preclinical
RMC-6236
Sensitive
:
D
RMC-6236
Sensitive: D – Preclinical
RMC-6236
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login